Comprehensive Characterization Of Oligonucleotides And Related Impurities Using Advanced LC/Q-TOF Analytical Workflows

Therapeutic oligonucleotides demand precise impurity profiling to ensure product safety, efficacy, and manufacturing consistency. Advanced two-dimensional LC/MS workflows can overcome the limitations of conventional one-dimensional approaches by separating and identifying closely related variants that often coelute with the target molecule. Using a model antisense oligonucleotide, researchers demonstrate how orthogonal chromatography, multiple heart-cutting, and high-resolution sampling improve the detection of low-level impurities, including truncations and backbone modifications. Automated sequence confirmation and impurity identification, supported by accurate mass and MS/MS data, provide deeper characterization of both the full-length product and structurally similar species.

See how the combined approach enhances analytical sensitivity, streamlines data interpretation, and offers a robust strategy for comprehensive oligonucleotide characterization.